MARKET

CEMI

CEMI

Chembio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.96
-0.14
-1.97%
Opening 12:00 09/23 EDT
OPEN
7.03
PREV CLOSE
7.10
HIGH
7.15
LOW
6.95
VOLUME
6.73K
TURNOVER
--
52 WEEK HIGH
10.79
52 WEEK LOW
4.390
MARKET CAP
122.26M
P/E (TTM)
-9.7684
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CEMI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CEMI News

  • Chembio Diagnostics (NASDAQ:CEMI) Has Debt But No Earnings; Should You Worry?
  • Simply Wall St..09/13 13:18
  • Chembio secures $20M term loan; shares ahead 13%
  • Seeking Alpha - Article.09/04 15:13
  • Chembio Diagnostics Announces $20 Million Term Loan with Perceptive Advisors
  • GlobeNewswire.09/04 13:00
  • Chembio Diagnostics Reports $20M Term Loan With Perceptive Advisors
  • Benzinga.09/04 12:12

More

Industry

Pharmaceuticals
-0.16%
Pharmaceuticals & Medical Research
-0.20%

Hot Stocks

Name
Price
%Change

About CEMI

Chembio Diagnostics, Inc. (Chembio), and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies, and a multiplex rapid test for the detection of HIV and Syphilis antibodies. The HIV 1/2 rapid tests employ in-licensed and lateral flow technologies that are used with all blood matrices as samples, and are manufactured in a standard cassette format, a dipstick format and a barrel format. Its HIV 1/2 rapid antibody detection test incorporates the Dual Path Platform (DPP) POCT technology. The DPP HIV 1/2 Assay detects antibodies to HIV 1 and 2 in oral fluid samples, as well as in all blood matrices. The Company's product pipeline includes a multiplex rapid test for earlier detection of HIV and a multiplex test that detects HIV and Syphilis specific antibodies.
More

Webull offers Chembio Diagnostics Inc (CEMI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.